(19)
(11) EP 2 616 478 A2

(12)

(88) Date of publication A3:
05.07.2012

(43) Date of publication:
24.07.2013 Bulletin 2013/30

(21) Application number: 11826047.0

(22) Date of filing: 16.09.2011
(51) International Patent Classification (IPC): 
C07K 7/08(2006.01)
A61K 38/10(2006.01)
C07D 473/18(2006.01)
C08B 3/06(2006.01)
C07K 7/06(2006.01)
A61K 38/08(2006.01)
C07D 401/12(2006.01)
A61P 31/20(2006.01)
(86) International application number:
PCT/US2011/052002
(87) International publication number:
WO 2012/037498 (22.03.2012 Gazette 2012/12)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 16.09.2010 US 383520 P

(71) Applicant: University Of Illinois
Chicago, Illinois 60612 (US)

(72) Inventors:
  • SHUKLA, Deepak
    Orland Park Illinois 60462 (US)
  • TIWARI, Vaibhav
    Chicago Illinois 60612 (US)

(74) Representative: Kremer, Simon Mark 
Mewburn Ellis LLP 33 Gutter Lane
London EC2V 8AS
London EC2V 8AS (GB)

   


(54) ANTI-HEPARAN SULFATE PEPTIDES THAT BLOCK HERPES SIMPLEX VIRUS INFECTION IN VIVO